GlassScriptPhysician profile
Kevin Hsu
NPI 1841298239
$13,871.19
in general payments reported to CMS, 2019-2025
27 companies · $2,822 in 2025
The $2,822 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,286 · 2020: $449 · 2021: $628 · 2022: $1,187 · 2023: $1,808 · 2024: $2,692 · 2025: $2,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,501 · Travel and Lodging: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,500.80 |
| Travel and Lodging | $820.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,194.52 | 2019-2025 | Aveir, Ensite, Gallant |
| Boston Scientific Corporation | $3,460.83 | 2019-2025 | Watchman Access System, Watchman Flx, Farapulse |
| E.R. Squibb & Sons, L.L.C. | $3,018.65 | 2019-2024 | Camzyos, Eliquis |
| Medtronic, INC. | $587.50 | 2021-2025 | Cobalt Dr Mri Surescan, Affera Mapping System, Micra |
| Kestra Medical Technology Services, INC. | $440.97 | 2023-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $373.21 | 2019-2020 | |
| Abiomed | $297.63 | 2024-2025 | Impella |
| Biosense Webster, INC. | $270.26 | 2022-2024 | Carto 3 |
| Amgen INC. | $168.81 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.50 | 2020-2025 | Lifevest |
| Novo Nordisk INC | $144.89 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $132.70 | 2021-2024 | Xarelto |
| Cardiva Medical, INC. | $101.40 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Novartis Pharmaceuticals Corporation | $85.52 | 2022-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $59.04 | 2024 | Arcalyst |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $58.11 | 2020-2021 | |
| Scpharmaceuticals INC. | $51.76 | 2023 | |
| Cvrx, INC. | $50.87 | 2025 | Barostim Neo System |
| Stryker Corporation | $46.59 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.03 | 2021-2024 | Jardiance |
| Pfizer INC. | $31.17 | 2023 | |
| Ethicon US, LLC | $24.17 | 2025 | Dermabond Prineo, Stratafix |
| Becton, Dickinson and Company | $20.36 | 2024 | |
| Convatec INC. | $18.70 | 2022 | |
| Elutia, INC. | $17.70 | 2023 | |
| Merck Sharp & Dohme LLC | $14.69 | 2024 | Verquvo |
| Irhythm Technologies, INC. | $13.61 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.